期刊文献+

深圳市可疑耐多药病人中的耐药结核病及其耐药谱分布特点 被引量:8

Analysis on situation and pattern of drug resistance tuberculosis in suspected multi-drug resistance patients in Shenzhen
下载PDF
导出
摘要 目的研究耐药结核病(DR-TB)在不同类型可疑耐多药结核病人(MDR-TB)中的分布特点及其耐药谱分布情况,为制定MDR-TB控制策略提供科学依据。方法 2006年10月—2009年4月深圳市发现的可疑耐多药结核病人为研究对象,通过痰涂片、培养、菌种鉴定和药物敏感试验诊断MDR-TB,按照可疑MDR-TB患者不同肺结核类型发生耐药和耐多药结核病情况进行统计分析。结果 406例临床分离菌株做药物敏感试验,其中36.2%为MDR-TB,18.9%为其他DR-TB;82例初治可疑MDR-TB患者中,MDR-TB占45.1%;310例复治可疑MDR-TB患者中,MDR-TB占33.2%,以复治失败所占比例最高,为66.7%。147例MDR-TB病例中,初治占28.6%,复治70.1%,新患者1.3%。77例其他DR-TB病例中,初治占22.1%,复治77.9%。初治组2类病例均有较高的MDR-TB和DR-TB发生率;复治组中复治失败病例的MDR-TB发生率最高。MDR-TB中,初治组以耐HRS和HRES为多,复治组以HR和HRES为多;MDR-TB外的其他DR-TB患者中,各耐药谱的耐药频率以单耐药为主,其中耐H或R的频度最高。结论复治组是MDR-TB发生的主要类别,但3个月末涂阳和初治失败患者也存在较高的MDR-TB发生率(实际上此病例已属复治);初、复治组MDR-TB均有较严重的耐药程度,其他DR-TB为发生MDR-TB的高危人群。 Objective To investigate the distribution characteristics and pattern of DR-TB in different types of suspected pulmonary MDR-TB patients and provide scientific evidence for MDR-TB control in Shenzhen. Methods All suspected MDR-TB found during October 2006 to April 2009 were investigated. Sputum smear,culture,bacterial identification and drug susceptibility test were performed for diagnosis of MDR-TB. Statistical analysis was made for the incidence rate of DR-TB and MDR-TB in different types of pulmonary MDR-TB patients. Results 406 isolated strains of Mycobacterium tuberculosis were tested for drug susceptibility,36.2% of them were diagnosed as MDR-TB; MDR-TB accounted for 45.1% and 33.2% respectively in 82 cases of initial and 310 cases of retreatment suspected MDR-TB cases. In the category of retreatment failure,the proportion of MDR-TB is the highest of 66.7%. Among 147 cases of MDR-TB,initial treatment,retreatment and new patients accounted for 28.6%,70.1% and 1.3% respectively. Of the 77 cases of other DR-TB,initial and retreatment PTB accounts for 22.1% and 77.9% respectively. The MDR-TB and DR-TB proportion are both high in two categories under initial treatment group. MDR-TB constituted the highest portion in retreatment failure category under retreatment group. In MDR-TB cases,the highest frequency is resistance to HRS and HRES in initial treatment group and HR and HRES in retreatment group. For other DR-TB patients,the majority is single drug resistance with highest frequency in H and R resistance. Conclusions Retreatment group was the major category for MDR-TB occurrence,however,there are also high MDR-TB incidence in those with smear positive results after 3 months treatment and those with initial treatment failure(in fact,these are already retreatment cases). Drug resistance is serious in both new and retreatment group. And other DR-TB is high risk population for MDR-TB.
出处 《中国防痨杂志》 CAS 2010年第6期318-322,共5页 Chinese Journal of Antituberculosis
基金 深圳市科技计划项目(200902094) 国家十一五科技重大专项:<结核病发病模式研究>(2008ZX10003-007)
关键词 结核 肺/药物疗法 抗药性 细菌 深圳市 tuberculosis pulmonary/drug therapy drug resistance bacterial Shenzhen city
  • 相关文献

参考文献10

  • 1中华人民共和国卫生部.2000年全国结核病流行病学抽样调查报告[R].北京:中华人民共和国卫生部,2002..
  • 2世界卫生组织.2009年世界结核病控制报告[R].日内瓦:世界卫生组织,2009.
  • 3杨本付,徐飚,蒋伟利,周佩源,姜庆五.苏北农村耐药结核病现状及影响因素的研究[J].中华流行病学杂志,2004,25(7):582-585. 被引量:17
  • 4王巍,姜平,李洪敏,冯柏,吴雪琼,陈东进,王安生,叶一秀,王仲元,刘金伟,陈红兵,林明贵,王金河,李素梅.结核分支杆菌耐药基因检测对获得性耐药性的研究[J].标记免疫分析与临床,2004,11(4):208-211. 被引量:3
  • 5徐旭卿,陈坤,李群.复治病人中影响耐药产生因素的分析[J].中国防痨杂志,2006,28(1):28-29. 被引量:22
  • 6Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, Chan CK, Leung CC. Risk factors for multidrug resistant tuberculosis in HongKong[J]. Int J Tuberc Lung Dis, 2008, 12 (9) : 1065-- 70.
  • 7He GX, Zhao YL, Jiang GL, Liu YH, Xia H, Wang SF, Wang LX, Borgdorff MW, van der Werf M J, van den Hof S. Prevalence of tuberculosis drug resistant in 10 provinces of China[J]. BMC Infect Dis,2008, 11(8) :166.
  • 8Meskel DW, Abate G, Lakew M, Goshu S, Aseffa A. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital [ J ]. Ethiop Med J, 2008, 46(3):219-225.
  • 9Sharma SK, Mohan A. Multidrug-resistant tuberculosist a menace that threatens to destabilize tuberculosis control[J]. Chest, 2006,130(1) : 261 - 272.
  • 10梅建,薛桢,沈鑫,沈国妙,桂晓红,沈梅,高谦.原发性耐药是耐药结核病产生的重要原因[J].中华结核和呼吸杂志,2006,29(2):75-78. 被引量:103

二级参考文献33

  • 1王甦民,刘宇红,姜广路.我国结核病耐药监测研究[J].中国防痨杂志,2003,25(z1):1-4. 被引量:8
  • 2李国明,周利平,刘勋,李爱国,李克国,袁方玉,杨占秋.湖北省不同年龄组和用药时间结核分枝杆菌耐药性的研究[J].武汉大学学报(医学版),2004,25(4):470-473. 被引量:5
  • 3沈国妙,查佳,徐琳,孙斌,桂晓红,王奕峰,梅建,高谦.结核分枝杆菌散在分布重复单位基因型分型法的应用研究[J].中华结核和呼吸杂志,2005,28(5):292-296. 被引量:28
  • 4结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 5World Health Organization,International Union Against Tuberculosis and Lung Disease.Anti-tuberculosis drug resistant in the world:the WHO/ IUATLD global project on anti-tuberculosis drug resistant surveillance:Report No.2[M].Prevalence and Trends.Geneva:WHO/IUATLD,2000:1-107.
  • 6Robert C,Cooksey, Morlock P, et al. Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York city[J].Antimicrob Agent Chemother, 1996,40:1186-1188.
  • 7Espinal MA, Laserson K, Camacho M,et al.Determinants of drug-resistant tuberculosis:analysis of 11 countries.Int J Tuberc Lung Dis, 2001,5:887-893.
  • 8World Health Organization, International Union Against Tuberculosis and Lung Disease.Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance: Report No.2.Prevalence and Trends.Geneva:
  • 9Taylor JP, Bergmire-Sweat D, Suarez L.Epidemiology of drug-resistant tuberculosis in Texas.Am J Epidemiol,1999,149:359-365.
  • 10Raviglione MC, Gupta R, Dye CM, et al.The burden of drug-resistant tuberculosis and mechanisms for its control.Ann N Y Acad Sci, 2001, 953:88-97.

共引文献147

同被引文献62

  • 1安燕生,丁北川,朱建华,邢青,贺晓新,靳敏芝,罗平,王甦民.北京市WHO结核病药物耐药性监测研究[J].中国防痨杂志,2007,29(6):475-478. 被引量:22
  • 2袁磊凌,李家政,邹远华,吴智龙.佛山市涂阳肺结核患者耐药情况分析[J].结核病与肺部健康杂志,2014,3(1):40-45. 被引量:10
  • 3仲崇霞,谢观利.江苏省沭阳县耐多药结核病治疗中的困惑[J].结核病与肺部健康杂志,2014,3(4):265-266. 被引量:1
  • 4杜长梅,王国斌,徐吉英,王国杰,胡惠义,甄新安,李爱华,孙占强,闫国蕊.河南省第二轮结核病耐药监测及耐药趋势研究[J].中国防痨杂志,2006,28(2):95-100. 被引量:26
  • 5卫生部.全国结核病耐药性基线调查报告[M].北京:人民军医出版社,2010,23-37.
  • 6Hinman AR, Hughes JM, Snider DX. Meeting the challengeof multidrug-resistant tuberculosis: summary of a conference. MMWR Reeomm Rep, 1992, 41(RR-11) :51-57.
  • 7World Health Organization. Anti-tuberculosis drug resistance in the world-fourth global report-2008. Geneva~WHO/HTM/ TB/2008,394.
  • 8中华人民共和国卫生部.全国结核病耐药基线调查报告(2007--2008年).北京:人民卫生出版社,2010.
  • 9中华人民共和国卫生部.全国结核病耐药性基线调查实施手册.北京:中华人民共和国卫生部,2006.
  • 10全国结核病耐药性基线调查办公室.全国结核病耐药性基线调查质量保证手册.北京:中国协和医科大学出版社,2007.

引证文献8

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部